THE USE OF PUBLISHED REAL-WORLD EVIDENCE IN HTA: AN ANALYSIS OF THE EVIDENCE BASE OF COMPANY SUBMISSIONS IN 2016 NICE APPRAISALS

被引：0
|
作者：
Van Lier, H. [1 ]
de Boeck, M. [1 ]
Edwards, V [1 ]
Hanekamp, E. [1 ]
Hartog, T. E. [1 ]
Richmond, G. [1 ]
van den Broek, R. [1 ]
机构：
[1] Excerpta Medica, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.076
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HT8
引用
收藏
页码：A410 / A410
页数：1
相关论文
共 50 条
  • [41] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113
  • [42] CAN YOU DESIGN AND CONDUCT A REAL-WORLD EVIDENCE STUDY THAT IS TRANSFERABLE BETWEEN HTA BODIES?
    Kolovos, S.
    Gaultney, J.
    Leproust, S.
    Guerra, I
    VALUE IN HEALTH, 2022, 25 (12) : S4 - S5
  • [43] REGULATORY VS HTA DIVERGENCES- CAN THE REAL-WORLD EVIDENCE (RWE) BE THE CONNECTING BRIDGE?
    Takyar, J.
    Gil, E.
    Gordon, M.
    Bergemann, R.
    VALUE IN HEALTH, 2024, 27 (06) : S384 - S384
  • [44] CONTEXT MATTERS - A TAXONOMY OF REAL-WORLD DATA AND EVIDENCE TO SUPPORT HTA DECISION-MAKING
    Murphy, L. A.
    Mestre-Ferrandiz, J.
    Sola-Morales, O.
    de Pouvourville, G.
    Cunningham, D.
    Corry, S.
    Akehurst, R.
    VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [45] LEVERAGING ELECTRONIC HEALTH RECORDS TO MEET THE REAL-WORLD EVIDENCE NEEDS OF HTA: A UK PERSPECTIVE
    Leahy, T.
    Ramagopalan, S.
    Sammon, C.
    VALUE IN HEALTH, 2019, 22 : S726 - S727
  • [46] Nationwide Etoricoxib Injection Clinical Experience (NICE): Real-World Evidence in Indian Patients
    Shetty, Umesh
    Neema, Pramod
    Muthu, S.
    Bhojwani, Divya
    Muchhala, Sameer
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [47] EXPLORING EFFICIENCY OF LIVING SYSTEMATIC LITERATURE REVIEW (SLR) TOOL FOR SUBMISSIONS OF CLINICAL EVIDENCE TO NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) BY COMBINING INTERVENTIONAL AND REAL-WORLD EVIDENCE (RWE)
    Liu, R.
    Agranat, J.
    Rizzo, M.
    Forsythe, A.
    VALUE IN HEALTH, 2023, 26 (12) : S349 - S349
  • [48] FACTORS INCLUDING REAL-WORLD EVIDENCE (RWE) THAT PLAY A ROLE IN THE HTA RECOMMENDATION OF ONCOLOGY DRUG SUBMISSIONS BASED ON PHASE II AND/OR SINGLE ARM TRIAL DATA
    Patel, Y.
    Manjrekar, S.
    Sripada, K.
    Liu, I
    Shum, D.
    VALUE IN HEALTH, 2023, 26 (06) : S262 - S263
  • [49] Use of Real-World Evidence in Hematology/Oncology Treatment Optimization
    Vose, Julie M.
    ONCOLOGY-NEW YORK, 2020, 34 (11): : 459 - 459
  • [50] USE OF REAL-WORLD EVIDENCE IN EUROPEAN MEDICINES AGENCY DECISIONS
    Watson, C.
    Jones, G.
    Shaw, C.
    VALUE IN HEALTH, 2022, 25 (12) : S8 - S8
12345